NCT02663518 2024-05-10A Trial of PF-07901800 (TTI-621) for Patients With Hematologic Malignancies and Selected Solid TumorsPfizerPhase 1 Terminated249 enrolled 43 charts
NCT03365791 2022-05-27PDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic MalignanciesNovartisPhase 2 Completed76 enrolled 14 charts
NCT00531284 2017-08-15Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or LymphomaAmgenPhase 1/2 Completed184 enrolled 36 charts
NCT00538850 2014-03-05Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainINSYS Therapeutics IncPhase 3 Completed130 enrolled 9 charts